Search

everythinglearnresearchcommunity

for

Search:↓

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Oral cyclosporine can help regrow hair in severe alopecia areata cases.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Squaric acid dibutylester effectively treats alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Alopecia areata significantly impacts patients' mental health and quality of life.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Low vitamin D levels are linked to severe and active alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.